New Melanoma Immunotherapy Drugs Giving Hope to Cancer Sufferers

  • 10 Apr 2017

Donate now to support melanoma research  Donate now

One of the biggest medical advances in recent years has been the development of effective immune therapy for melanoma. Many patients respond very well to immune therapy, even when their cancer has spread throughout their bodies, and for some patients it seems likely that wakening their immune system has now cured them of their cancer. The video from this weekend’s article in the NZ Herald describes the journey of one patient receiving Keytruda for her melanoma in her own words.

But despite the excitement, many patients aren’t helped by the current immune therapy drugs, which raises some very obvious questions that can be addressed with biomedical research funded by the Auckland Medical Research Foundation: Why do some people respond to current immune therapy while others don’t? What new combinations of therapies might help more patients? Can we imagine effective immune therapy for everyone with melanoma? And how does all of this affect the future of treating other cancers?

You can view the 2016 lecture we hosted with Professor Rod Dunbar about Immunotherapy here:

Read the whole New Zealand Herald article:

More News
Prestigious cardiovascular publication for AMRF researchers
Professor Jane Harding receives prestigious award for newborn baby research
AMRF contributes to world class research comparing best emergency practice for child head injuries
Giving in Your Lifetime
Endometriosis Research in the News
PM Bill English supports Medical Research success